MedTrace Logo

Assessment of Complication Risk Factors in a French National Cohort of Asplenic Patients

NCT04199403 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2024-02-01

No results posted yet for this study

Summary

Spleen could have been surgically removed for trauma, cancer, auto-immune disease, or to perform a diagnosis. Spleen could be non-functional due to radiotherapy or splenic artery embolism. These patients are at risks of infectious diseases due to encapsulated bacteria, cancer, and thromboembolism disease. The purpose of this study is to assess complications occurring in French patients without spleen and to implement new diagnostic tools for follow-up.

Conditions

  • Asplenia

Sponsors & Collaborators

  • Pr Pierre BUFFET Institut National de la Transfusion Sanguine

    collaborator UNKNOWN

  • Dr Edouard TUAILLON Département Bactériologie-Virologie/INSERM U1058 CHU de Montpellier

    collaborator UNKNOWN

  • Poitiers University Hospital

    lead OTHER

Principal Investigators

  • Mathieu PUYADE, MD · C.H.U. de Poitiers

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-09
Primary Completion
2040-01-31
Completion
2040-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04199403 on ClinicalTrials.gov